This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 22:7:326.
doi: 10.1186/1756-3305-7-326.

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected

Affiliations

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected

Honorat G M Zouré et al. Parasit Vectors. .

Abstract

Background: The original aim of the African Programme for Onchocerciasis Control (APOC) was to control onchocerciasis as a public health problem in 20 African countries. In order to identify all high risk areas where ivermectin treatment was needed to achieve control, APOC used Rapid Epidemiological Mapping of Onchocerciasis (REMO). REMO involved spatial sampling of villages to be surveyed, and examination of 30 to 50 adults per village for palpable onchocercal nodules. REMO has now been virtually completed and we report the results in two articles. A companion article reports the delineation of high risk areas based on expert analysis. The present article reports the results of a geostatistical analysis of the REMO data to map endemicity levels and estimate the number infected.

Methods: A model-based geostatistical analysis of the REMO data was undertaken to generate high-resolution maps of the predicted prevalence of nodules and of the probability that the true nodule prevalence exceeds the high risk threshold of 20%. The number infected was estimated by converting nodule prevalence to microfilaria prevalence, and multiplying the predicted prevalence for each location with local data on population density. The geostatistical analysis included the nodule palpation data for 14,473 surveyed villages.

Results: The generated map of onchocerciasis endemicity levels, as reflected in the prevalence of nodules, is a significant advance with many new endemic areas identified. The prevalence of nodules was > 20% over an area of 2.5 million km2 with an estimated population of 62 million people. The results were consistent with the delineation of high risk areas of the expert analysis except for borderline areas where the prevalence fluctuated around 20%. It is estimated that 36 million people would have been infected in the APOC countries by 2011 if there had been no ivermectin treatment.

Conclusions: The map of onchocerciasis endemicity levels has proven very valuable for onchocerciasis control in the APOC countries. Following the recent shift to onchocerciasis elimination, the map continues to play an important role in planning treatment, evaluating impact and predicting treatment end dates in relation to local endemicity levels.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Map of the observed prevalence of palpable nodules in the 14,473 surveyed villages.
Figure 2
Figure 2
Map of the estimated prevalence of palpable nodules in the 20 APOC countries.
Figure 3
Figure 3
Map of the predictive probability that the local prevalence of nodules exceeds 20%.

References

    1. World Health Organization. Onchocerciasis and its Control. Report of a WHO Expert Committee on Onchocerciasis Control. Geneva: World Health Organization; 1995. pp. 1–104. - PubMed
    1. Boatin B. The Onchocerciasis Control Programme in West Africa (OCP) Ann Trop Med Parasitol. 2008;102(Suppl 1):13–17. - PubMed
    1. Thylefors B. The Mectizan Donation Program (MDP) Ann Trop Med Parasitol. 2008;102(Suppl 1):39–44. - PubMed
    1. Gustavsen K, Hopkins A, Sauerbrey M. Onchocerciasis in the Americas: from arrival to (near) elimination. Parasit Vectors. 2011;4:205. doi: 10.1186/1756-3305年4月20日5. - DOI - PMC - PubMed
    1. Tielsch JM, Beeche A. Impact of ivermectin on illness and disability associated with onchocerciasis. Trop Med Int Health. 2004;9(4):A45–A56. doi: 10.1111/j.1365-3156.2004.01213.x. - DOI - PubMed

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /